Search research articles
Contact Us
Filters
Showing results (601-610 of 621) with videos related to
Page
of 63
Sort By:
Journal of Neurology
|
July 2, 2025
Comparative effectiveness of teriflunomide and ocrelizumab on smoldering activity in multiple sclerosis: an observational study in the Swiss Multiple Sclerosis Cohort
Alessandro Cagol, Sabine Schaedelin, Mario Ocampo-Pineda, et al.
JAMA Neurology
|
November 6, 2023
Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis
Ahmed Abdelhak, Pascal Benkert, Sabine Schaedelin, et al.
Annals of Neurology
|
May 31, 2021
Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis
Johanna Oechtering, Sabine Schaedelin, Pascal Benkert, et al.
Journal of Neurology
|
May 15, 2023
Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis
Ahmed Abdelhak, Lorenzo Barba, Michele Romoli, et al.
JAMA Neurology
|
February 6, 2023
Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis
Stephanie Meier, Eline A J Willemse, Sabine Schaedelin, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 8, 2023
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis
Nicolás Fissolo, Pascal Benkert, Jaume Sastre-Garriga, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
January 3, 2025
Aberrant Complement Activation Is Associated With Structural Brain Damage in Multiple Sclerosis
Johanna Oechtering, Sabine Anna Schaedelin, Kerstin Stein, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
December 6, 2024
Disease-modifying treatment and disability progression in subclasses of patients with primary progressive MS: results from the Big MS Data Network
Johannes Lorscheider, Alessio Signori, Suvitha Subramaniam, et al.
Annals of Clinical and Translational Neurology
|
August 4, 2025
Serum Neurofilament Light Chain in Multiple Sclerosis: Superiority of Age- and BMI-Corrected Z Scores/Percentiles Over Absolute Cutoff Values for Prediction of Treatment Response
Maximilian Einsiedler, Aleksandra Maleska Maceski, Sofia Sandgren, et al.
Bioengineering (Basel, Switzerland)
|
August 29, 2024
Contrast-Enhancing Lesion Segmentation in Multiple Sclerosis: A Deep Learning Approach Validated in a Multicentric Cohort
Martina Greselin, Po-Jui Lu, Lester Melie-Garcia, et al.
Page
of 63
Search research articles
Search
Showing results (601-610 of 621) with videos related to
Sort By:
Page
of 63
Journal of Neurology
|
July 2, 2025
Comparative effectiveness of teriflunomide and ocrelizumab on smoldering activity in multiple sclerosis: an observational study in the Swiss Multiple Sclerosis Cohort
Alessandro Cagol, Sabine Schaedelin, Mario Ocampo-Pineda, et al.
JAMA Neurology
|
November 6, 2023
Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis
Ahmed Abdelhak, Pascal Benkert, Sabine Schaedelin, et al.
Annals of Neurology
|
May 31, 2021
Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis
Johanna Oechtering, Sabine Schaedelin, Pascal Benkert, et al.
Journal of Neurology
|
May 15, 2023
Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis
Ahmed Abdelhak, Lorenzo Barba, Michele Romoli, et al.
JAMA Neurology
|
February 6, 2023
Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis
Stephanie Meier, Eline A J Willemse, Sabine Schaedelin, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 8, 2023
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis
Nicolás Fissolo, Pascal Benkert, Jaume Sastre-Garriga, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
January 3, 2025
Aberrant Complement Activation Is Associated With Structural Brain Damage in Multiple Sclerosis
Johanna Oechtering, Sabine Anna Schaedelin, Kerstin Stein, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
December 6, 2024
Disease-modifying treatment and disability progression in subclasses of patients with primary progressive MS: results from the Big MS Data Network
Johannes Lorscheider, Alessio Signori, Suvitha Subramaniam, et al.
Annals of Clinical and Translational Neurology
|
August 4, 2025
Serum Neurofilament Light Chain in Multiple Sclerosis: Superiority of Age- and BMI-Corrected Z Scores/Percentiles Over Absolute Cutoff Values for Prediction of Treatment Response
Maximilian Einsiedler, Aleksandra Maleska Maceski, Sofia Sandgren, et al.
Bioengineering (Basel, Switzerland)
|
August 29, 2024
Contrast-Enhancing Lesion Segmentation in Multiple Sclerosis: A Deep Learning Approach Validated in a Multicentric Cohort
Martina Greselin, Po-Jui Lu, Lester Melie-Garcia, et al.
Page
of 63